Southern Acids (M) Bhd (KLSE:5134) — Stock Price
Southern Acids (M) Bhd (KLSE:5134) is currently trading at RM3.01 MYR, down 0.66% today. Over the past 52 weeks, shares have ranged between RM3.00 and RM3.50. This page tracks Southern Acids (M) Bhd's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 5134 market cap.
Southern Acids (M) Bhd (5134) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Southern Acids (M) Bhd's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Southern Acids (M) Bhd Income Statement — Revenue, Profit & Earnings by Year
Southern Acids (M) Bhd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | RM1.09 Billion | RM907.96 Million | RM1.10 Billion | RM1.18 Billion | RM741.10 Million |
| Cost of Revenue | RM865.51 Million | RM732.02 Million | RM861.80 Million | RM883.41 Million | RM538.15 Million |
| Gross Profit | RM225.02 Million | RM175.94 Million | RM238.08 Million | RM292.84 Million | RM202.95 Million |
| Research & Development | — | — | — | — | — |
| SG&A | RM87.89 Million | RM81.53 Million | RM81.26 Million | RM76.74 Million | RM69.34 Million |
| Total Operating Expenses | RM1.02 Billion | RM863.44 Million | RM1.03 Billion | RM1.03 Billion | RM685.01 Million |
| Operating Income | RM73.69 Million | RM44.52 Million | RM75.70 Million | RM150.61 Million | RM60.92 Million |
| EBITDA | — | — | RM100.17 Million | RM174.22 Million | RM82.74 Million |
| EBIT | — | — | RM75.71 Million | RM150.61 Million | RM60.92 Million |
| Interest Expense | RM15.44 Million | RM12.24 Million | RM6.86 Million | RM4.63 Million | RM4.82 Million |
| Income Before Tax | RM72.26 Million | RM43.17 Million | RM74.91 Million | RM149.85 Million | RM60.34 Million |
| Income Tax Expense | — | — | RM20.91 Million | RM31.73 Million | RM12.56 Million |
| Net Income | RM36.70 Million | RM13.63 Million | RM33.29 Million | RM94.42 Million | RM37.36 Million |
Southern Acids (M) Bhd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Southern Acids (M) Bhd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | RM1.01 Billion | RM1.02 Billion | RM972.74 Million | RM968.48 Million | RM810.78 Million |
| Total Current Assets | RM608.61 Million | RM612.70 Million | RM591.77 Million | RM593.12 Million | RM433.06 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | RM190.41 Million | RM188.40 Million | RM179.22 Million | RM131.91 Million | RM139.77 Million |
| Net Receivables | RM48.23 Million | RM61.94 Million | RM56.41 Million | RM73.28 Million | RM51.34 Million |
| Inventory | RM86.24 Million | RM78.73 Million | RM89.26 Million | RM112.40 Million | RM82.39 Million |
| Property, Plant & Equipment | RM207.04 Million | RM212.51 Million | RM203.12 Million | RM197.90 Million | RM198.78 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | RM228.16 Million | RM239.37 Million | RM217.81 Million | RM241.01 Million | RM173.12 Million |
| Total Current Liabilities | RM92.73 Million | RM102.66 Million | RM75.93 Million | RM115.40 Million | RM73.90 Million |
| Long-term Debt | — | RM0.00 | RM900.00K | RM2.10 Million | RM3.30 Million |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | RM779.74 Million | RM779.57 Million | RM754.93 Million | RM727.47 Million | RM637.66 Million |
| Retained Earnings | RM630.29 Million | RM601.72 Million | RM591.01 Million | RM564.41 Million | RM476.27 Million |
Southern Acids (M) Bhd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Southern Acids (M) Bhd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | RM51.25 Million | RM27.98 Million | RM108.89 Million | RM85.17 Million | RM48.50 Million |
| Capital Expenditures | RM38.58 Million | RM33.88 Million | RM25.80 Million | RM20.42 Million | RM22.96 Million |
| Free Cash Flow | RM17.45 Million | RM-5.90 Million | RM84.81 Million | RM64.75 Million | RM24.87 Million |
| Investing Cash Flow | RM-26.29 Million | RM-26.42 Million | RM-15.51 Million | RM-14.56 Million | RM-7.68 Million |
| Financing Cash Flow | RM-16.24 Million | RM7.35 Million | RM-31.12 Million | RM6.17 Million | RM-11.89 Million |
| Dividends Paid | RM6.85 Million | RM6.85 Million | RM6.85 Million | RM6.85 Million | RM6.85 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | RM26.10 Million | RM24.86 Million | RM24.32 Million | RM23.57 Million | RM21.92 Million |
| Change in Cash | RM-11.55 Million | RM10.99 Million | RM63.29 Million | RM80.12 Million | RM33.23 Million |
Southern Acids (M) Bhd Earnings History — EPS Actual vs. Analyst Estimates
Track Southern Acids (M) Bhd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 0.04 | — | — |
| Dec 02, 2025 | 0.07 | — | — |
| Aug 29, 2025 | 0.00 | — | — |
| May 29, 2025 | 0.04 | — | — |
| Feb 19, 2025 | 0.18 | — | — |
| Nov 26, 2024 | 0.04 | — | — |
| Aug 23, 2024 | 0.01 | — | — |
| May 30, 2024 | 0.04 | — | — |